Trifarma Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is MINOXIDIL USP, with a corresponding US DMF Number 5977.
Remarkably, this DMF maintains an Active status since its submission on August 19, 1985, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 05, 2014, and payment made on August 04, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II